Mansion-Tassin SRL
Mansion-Tassin reported total assets of 648,936 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 May 2026).
The score of Mansion-Tassin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +55 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mansion-Tassin's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 28 Mar 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 02 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Mansion-Tassin's financial analysis
- Solvency54.1%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mansion-Tassin
Mansion-Tassin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0553.916.025
- VAT number
- BE0553916025
- Peppol
- Registered · 0208:0553916025 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Jun 2014
- Registered office
- 4610 Beyne-Heusay
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mansion-Tassin (SRL) has been based in Beyne-Heusay since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 55,431 € and equity of 351,371 €; its revenue is not published. Its solvency stands at 54.1%, above the median of its sector (40.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mansion-Tassin
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Vandervoort Retail sale of pharmaceutical products Balen · balance sheet 644,949 €
- Corum Retail sale of pharmaceutical products Ghent · balance sheet 641,387 €
- Maudens Jeroen Retail sale of pharmaceutical products Sint-Genesius-Rode · balance sheet 633,969 €
- Piret Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 675,213 €
- MieTon Retail sale of pharmaceutical products Hoogstraten · balance sheet 705,749 €
- Caro Pharma Retail sale of pharmaceutical products Erquelinnes · balance sheet 593,057 €
- Emanuel - van Hauwermeiren Retail sale of pharmaceutical products Dendermonde · balance sheet 588,306 €
Frequently asked questions about Mansion-Tassin
What is the revenue of Mansion-Tassin?
Mansion-Tassin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mansion-Tassin?
In Belgium, the VAT number is the company number prefixed with BE: BE0553916025 for Mansion-Tassin, if the company is VAT-registered. Its company number (CBE) is 0553.916.025.
Where is the registered office of Mansion-Tassin?
According to the CBE register, the registered office of Mansion-Tassin is in 4610 Beyne-Heusay.
What is the equity of Mansion-Tassin?
At the close of the 2025 financial year, the equity of Mansion-Tassin amounts to 351,371 €, a solvency of 54.1% of total assets.
Who manages Mansion-Tassin?
The register lists 1 active mandates at Mansion-Tassin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mansion-Tassin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →